Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Epigenetic therapy for Friedreich's ataxia

OBJECTIVE:

To investigate whether a histone deacetylase inhibitor (HDACi) would be effective in an in vitro model for the neurodegenerative disease Friedreich ataxia (FRDA) and to evaluate safety and surrogate markers of efficacy in a phase I clinical trial in patients.

Read More: Epigenetic therapy for Friedreich's ataxia

SHARE

FacebookTwitterLinkedInYoutube
Science A.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News


Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator